Dapagliflozin 10 mg Clinical Trials
8 recruitingDrug
Phase 34Phase 22Phase 12
Showing 1–8 of 8 trials
Recruiting
Phase 3
STOP-PKD: SGLT2-inhibition to Improve Prognosis in Polycystic Kidney Disease
Polycystic Kidney, Autosomal Dominant
University of Cologne420 enrolled27 locationsNCT07280585
Recruiting
Phase 2
Use of Dapagliflozin in Primary Prevention of Cardiotoxicity of Anthracycline Chemotherapy in Breast Cancer Patients
Breast CancerHeart FailureAnthracycline-induced Cardiac Toxicity+2 more
University Medical Centre Ljubljana100 enrolled1 locationNCT07245069
Recruiting
Phase 1
A Study to Evaluate the Pharmacokinetics and Safety Between "BR3006" and Co-administration of "BR3006A", "BR3006B", and "BR3006C" in Healthy Adult Volunteers (Fasting)
Diabetes Mellitus
Boryung Pharmaceutical Co., Ltd52 enrolled1 locationNCT07083388
Recruiting
Phase 1
A Study to Evaluate the Pharmacokinetics and Safety Between "BR3006" and Co-administration of "BR3006A", "BR3006B", and "BR3006C" in Healthy Adult Volunteers (Fed)
Diabete Mellitus
Boryung Pharmaceutical Co., Ltd40 enrolled1 locationNCT07083401
Recruiting
Phase 3
Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Kidney Function in Advanced Chronic Kidney Disease
Chronic Kidney Disease Stage 5CKD Stage 4
Ain Shams University60 enrolled1 locationNCT06982079
Recruiting
Phase 2
Effects of Dapagliflozin on EChOcardiographic Measures of CarDiac StructurE and Function in Patients with CKD
Chronic Kidney Diseases
Tor Biering-Sørensen222 enrolled1 locationNCT05359263
Recruiting
Phase 3
Effect of DAPAglifozin on MYOcardial Remodeling of Breast CANCER Patients Treated with Anthracycline Based Chemotherapy
Breast Cancer
University of Campinas, Brazil80 enrolled1 locationNCT06711185
Recruiting
Phase 3
DAPAgliflozin for Renal Protection in Heart Transplant Recipients
Kidney FailureHeart Transplant Failure
Oslo University Hospital430 enrolled6 locationsNCT05321706